Tango Therapeutics
A Translational Scientist at Tango Therapeutics leads clinical biomarker development, in vitro diagnostic, and companion diagnostic activities to support clinical trials. The role involves cross-functional collaboration and operational management of clinical biomarker assays.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
15% above the average for this role
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Associate Director, Companion Diagnostic (CDx) Strategy and Development
Regeneron Pharmaceuticals
Scientist/Senior Scientist, Clinical Pathology & IHC
Systimmune
Senior Director Diagnostic Assays/Cancer Biomarker Development
AstraZeneca
Associate Director, Companion Diagnostic (CDx) Strategy and Development
Regeneron Pharmaceuticals
Clinical Biomarker Lead
Janux Therapeutics
Associate Director, Clinical Biomarker
lifelancer